A groundbreaking meta-analysis, encompassing a vast array of prior research, suggests that the efficacy of exercise therapy in mitigating the symptoms of osteoarthritis (OA) may be considerably less impactful and more transient than widely assumed. Published in the peer-reviewed journal RMD Open, this comprehensive examination challenges long-standing clinical recommendations that routinely position physical activity as the primary intervention for individuals grappling with this prevalent degenerative joint condition. The authors contend that for some patients, the perceived benefits of structured exercise might scarcely surpass those of receiving no treatment at all, prompting a critical re-evaluation of therapeutic strategies and future research priorities in musculoskeletal health.
Osteoarthritis, often colloquially referred to as "wear and tear" arthritis, represents a chronic condition characterized by the breakdown of cartilage cushioning the ends of bones, leading to pain, stiffness, and reduced mobility. Globally, hundreds of millions are affected, making it a leading cause of disability. Conventional medical wisdom has long advocated for exercise as a cornerstone of OA management, largely due to its non-pharmacological nature, low cost, safety profile, and well-documented systemic health advantages such as improved cardiovascular health, weight management, and mental well-being. Clinical guidelines from numerous professional bodies typically recommend exercise as a first-line approach, aiming to strengthen supporting muscles, enhance joint stability, and alleviate discomfort. However, a growing body of evidence, often fragmented across individual studies, has begun to cast doubt on the extent and durability of exercise’s specific impact on OA pain and functional improvement.
Recognizing this emerging complexity and the absence of a consolidated, overarching synthesis, researchers embarked on an ambitious project: an umbrella systematic review and pooled analysis. This rigorous methodology involves systematically identifying, appraising, and synthesizing data from existing systematic reviews and randomized controlled trials (RCTs), providing a higher level of evidence than individual studies. The primary objective was to comprehensively compare exercise therapy directly against a spectrum of alternatives, including placebo interventions, standard care, no treatment, various medications, other non-surgical therapies, and even surgical procedures. This holistic approach aimed to bridge critical gaps in understanding how exercise truly measures up across the full therapeutic landscape for osteoarthritis.
To execute this extensive investigation, the research team conducted a thorough search of prominent academic databases, scrutinizing literature published up to November 2025. Their meticulous selection process ultimately incorporated five existing systematic reviews, collectively encompassing data from 8,631 participants, alongside 28 individual randomized clinical trials involving 4,360 patients. The focus of these studies spanned various anatomical sites commonly afflicted by osteoarthritis, with the majority addressing knee or hip OA (23 studies), followed by hand OA (3 studies), and ankle OA (2 studies). This broad inclusion criteria allowed for a nuanced assessment across different joint presentations.
Upon aggregating the findings, a consistent pattern emerged, particularly concerning osteoarthritis of the knee. The analysis indicated that exercise was associated with only minor and fleeting reductions in knee pain when compared to either a placebo or the absence of any intervention. Crucially, the overall confidence in this particular evidence was deemed "very low," suggesting substantial uncertainty regarding the true effect size. Furthermore, the researchers observed a diminishing return: in studies characterized by larger participant cohorts or extended follow-up periods, the observed benefits of exercise appeared even more negligible. This trend implies that any initial, modest improvements might not be sustained over time, raising questions about long-term efficacy.
For other major joints, the conclusions varied slightly but generally reinforced the theme of limited impact. In cases of hip osteoarthritis, the evidence, which was considered of moderate certainty, pointed towards an almost imperceptible improvement in symptoms. Similarly, data pertaining to hand osteoarthritis suggested only marginal effects. These findings collectively challenge the widespread assumption of substantial, consistent benefits from exercise across all forms of OA, urging a more granular and evidence-based perspective. The concept of "clinically meaningful improvement," a threshold often used to determine if a treatment’s effect is significant enough to impact a patient’s daily life, appeared to be rarely met by exercise interventions alone for pain reduction in many of these scenarios.
Beyond comparisons with placebo or no treatment, the review also assessed exercise’s relative performance against other common therapeutic modalities. Interestingly, exercise therapy generally demonstrated comparable effectiveness to patient education programs, various forms of manual therapy, commonly prescribed pain medications, and intra-articular injections of corticosteroids or hyaluronic acid. Even when weighed against arthroscopic knee surgery—a minimally invasive procedure—exercise typically yielded similar outcomes in terms of pain and function, though the certainty of evidence for these comparisons varied. However, in specific trials focusing on particular patient subgroups, exercise was found to be less effective over the long term than more invasive surgical interventions such as knee bone remodeling surgery (osteotomy) or total joint replacement, highlighting the potential for more definitive, albeit higher-risk, solutions in advanced cases.
The authors conscientiously acknowledged several inherent limitations within their comprehensive review. One such limitation involved the prioritization of specific systematic reviews for inclusion, which inevitably meant that some relevant primary studies might not have been directly incorporated into the main analysis. Nevertheless, the researchers addressed this by examining effect sizes from these omitted reviews, finding that their conclusions largely aligned with the primary analysis. Further challenges included the frequent absence of direct, head-to-head comparative trials between exercise and many alternative treatments, requiring indirect comparisons. Moreover, the diverse characteristics of participants across studies—ranging widely in symptom severity, disease duration, and overall health status—introduced heterogeneity that could influence outcomes. Lastly, the allowance of additional, concurrent treatments alongside exercise in some trials presented a confounding factor, making it difficult to isolate the precise effects attributable solely to exercise.
Despite these caveats, the overarching conclusions drawn by the research team are unequivocal and have significant implications for clinical practice. Their synthesis points to "largely inconclusive evidence on exercise for osteoarthritis, suggesting negligible or, at best, short-lasting small effects on pain and function across different types of osteoarthritis compared with placebo or no treatment." The observation that these effects become "less pronounced in larger and longer-term trials" further underscores the ephemeral nature of the benefits. Consequently, the authors explicitly question the universal recommendation of exercise therapy as the exclusive or primary focus in first-line treatment strategies aimed at improving pain and physical function for all patients suffering from osteoarthritis.
Crucially, the researchers are careful to emphasize that these findings do not negate the myriad other health benefits associated with regular physical activity. Exercise remains a powerful tool for improving cardiovascular health, managing weight, enhancing mood, and reducing the risk of other chronic diseases. For some individuals, these secondary advantages, coupled with a subjective perception of pain relief, may still make exercise a preferred and valuable component of their overall health regimen. Therefore, the call is not to abandon exercise but rather to adopt a more nuanced and patient-centered approach to OA management.
The experts advocate for "shared decision-making" between clinicians and patients. This collaborative model encourages a thorough discussion of all available treatment options, weighing the often-modest effects of exercise on pain and function against its broader health benefits, safety profile, low financial cost, the individual’s stage of care, and the viability of alternative therapies. This paradigm shift encourages healthcare providers to move beyond a one-size-fits-all prescription and instead tailor recommendations to each patient’s unique circumstances, preferences, and clinical presentation.
Ultimately, this extensive review serves as a powerful catalyst for re-evaluating established practices and recalibrating research priorities within the field of osteoarthritis. Future investigations may need to focus more intently on identifying specific subgroups of patients who are most likely to benefit from particular types of exercise, exploring optimal exercise regimens, or investigating the synergistic effects of exercise when combined with other therapeutic interventions. The aim is to move towards an era of more precise, individualized, and evidence-informed care for the millions living with the daily challenges of osteoarthritis.
About the Author
